v3.26.1
Organization and Business Overview (Details Narrative) - USD ($)
$ / shares in Units, $ in Thousands
6 Months Ended
Nov. 06, 2025
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Oct. 20, 2025
Jun. 16, 2025
Shares, Issued   2,332,803        
Preferred Stock, Par or Stated Value Per Share   $ 0.001   $ 0.001   $ 0.001
Proceeds from Sale of Intangible Assets $ 3,000          
Net cash outflows from operations   $ 1,728 $ 7,162      
Accumulated deficit   133,301   $ 127,945    
Cash and cash equivalents   4,659   $ 6,392    
Private Placement [Member]            
[custom:SalesMilestonePaymentsAmount-0]   $ 1,000        
Maximum [Member]            
Variable consideration contingent $ 7,000          
Investor [Member]            
Investments         $ 11,000  
Biofrontera Group [Member] | Series D Convertible Preferred Stock [Member]            
Shares, Issued         3,019  
Preferred Stock, Par or Stated Value Per Share         $ 0.001